Pfizer Agrees to Buy Seagen for $43 Billion - The Wall Street Journal
- Pfizer Agrees to Buy Seagen for $43 Billion The Wall Street Journal
- Pfizer looks beyond Covid sales with $43 billion deal for cancer drugmaker Seagen CNBC
- Pfizer to purchase Seagen in $43 billion all-cash deal, cancer biotech's stock pops 20% MarketWatch
- Pfizer Invests $43 Billion to Battle Cancer Yahoo Finance
- Pfizer set to buy oncology-focused biotech SeaGen in $43bn deal Financial Times
- View Full Coverage on Google News